| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 131 | 133 | PF00675 | 0.401 |
| CLV_PCSK_KEX2_1 | 131 | 133 | PF00082 | 0.401 |
| CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.430 |
| CLV_PCSK_PC1ET2_1 | 17 | 19 | PF00082 | 0.430 |
| CLV_PCSK_SKI1_1 | 53 | 57 | PF00082 | 0.555 |
| CLV_PCSK_SKI1_1 | 80 | 84 | PF00082 | 0.587 |
| DEG_SPOP_SBC_1 | 160 | 164 | PF00917 | 0.546 |
| DOC_CYCLIN_RxL_1 | 51 | 60 | PF00134 | 0.466 |
| DOC_CYCLIN_RxL_1 | 77 | 85 | PF00134 | 0.446 |
| DOC_MAPK_gen_1 | 108 | 115 | PF00069 | 0.485 |
| DOC_MAPK_gen_1 | 53 | 59 | PF00069 | 0.552 |
| DOC_MAPK_gen_1 | 80 | 90 | PF00069 | 0.575 |
| DOC_PP1_RVXF_1 | 78 | 85 | PF00149 | 0.323 |
| DOC_USP7_MATH_1 | 153 | 157 | PF00917 | 0.528 |
| DOC_USP7_MATH_1 | 160 | 164 | PF00917 | 0.565 |
| DOC_USP7_MATH_1 | 39 | 43 | PF00917 | 0.531 |
| DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.410 |
| LIG_14-3-3_CanoR_1 | 122 | 130 | PF00244 | 0.379 |
| LIG_14-3-3_CanoR_1 | 132 | 141 | PF00244 | 0.434 |
| LIG_Actin_WH2_2 | 40 | 55 | PF00022 | 0.337 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.412 |
| LIG_eIF4E_1 | 51 | 57 | PF01652 | 0.299 |
| LIG_LIR_Gen_1 | 25 | 33 | PF02991 | 0.502 |
| LIG_LIR_Gen_1 | 38 | 47 | PF02991 | 0.504 |
| LIG_LIR_Nem_3 | 25 | 31 | PF02991 | 0.504 |
| LIG_LIR_Nem_3 | 38 | 43 | PF02991 | 0.560 |
| LIG_SH2_CRK | 40 | 44 | PF00017 | 0.533 |
| LIG_SH2_STAT3 | 19 | 22 | PF00017 | 0.329 |
| LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.535 |
| LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.493 |
| LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.551 |
| LIG_SH3_3 | 99 | 105 | PF00018 | 0.376 |
| LIG_SUMO_SIM_anti_2 | 136 | 142 | PF11976 | 0.388 |
| LIG_SUMO_SIM_par_1 | 139 | 144 | PF11976 | 0.358 |
| LIG_SUMO_SIM_par_1 | 55 | 60 | PF11976 | 0.463 |
| LIG_SUMO_SIM_par_1 | 67 | 74 | PF11976 | 0.295 |
| MOD_CK1_1 | 136 | 142 | PF00069 | 0.554 |
| MOD_CK1_1 | 156 | 162 | PF00069 | 0.373 |
| MOD_CK1_1 | 60 | 66 | PF00069 | 0.511 |
| MOD_CK2_1 | 103 | 109 | PF00069 | 0.469 |
| MOD_CK2_1 | 160 | 166 | PF00069 | 0.516 |
| MOD_CK2_1 | 70 | 76 | PF00069 | 0.463 |
| MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.362 |
| MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.430 |
| MOD_GlcNHglycan | 84 | 87 | PF01048 | 0.405 |
| MOD_GlcNHglycan | 96 | 99 | PF01048 | 0.380 |
| MOD_GSK3_1 | 156 | 163 | PF00069 | 0.641 |
| MOD_GSK3_1 | 39 | 46 | PF00069 | 0.586 |
| MOD_GSK3_1 | 55 | 62 | PF00069 | 0.422 |
| MOD_N-GLC_2 | 125 | 127 | PF02516 | 0.402 |
| MOD_NEK2_1 | 43 | 48 | PF00069 | 0.526 |
| MOD_NEK2_1 | 57 | 62 | PF00069 | 0.564 |
| MOD_NEK2_1 | 82 | 87 | PF00069 | 0.306 |
| MOD_Plk_2-3 | 70 | 76 | PF00069 | 0.485 |
| MOD_Plk_4 | 136 | 142 | PF00069 | 0.300 |
| MOD_Plk_4 | 47 | 53 | PF00069 | 0.574 |
| MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.397 |
| TRG_ENDOCYTIC_2 | 28 | 31 | PF00928 | 0.567 |
| TRG_ENDOCYTIC_2 | 40 | 43 | PF00928 | 0.412 |
| TRG_ER_diArg_1 | 130 | 132 | PF00400 | 0.387 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1IJ09 | Leptomonas seymouri | 66% | 97% |
| A0A1X0NLF4 | Trypanosomatidae | 48% | 100% |
| A0A3R7KUB4 | Trypanosoma rangeli | 46% | 99% |
| A0A451EJV1 | Leishmania donovani | 80% | 100% |
| A4HS00 | Leishmania infantum | 80% | 100% |
| C9ZXZ5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 47% | 100% |
| E9ACP5 | Leishmania major | 78% | 100% |
| E9AJY8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 100% |